CarH3 Degradation and Anti-CarP Antibody Protection Assay

Exploratory Score: 0.900 Price: $0.50 rheumatoid arthritis in vitro protein degradation assay Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting histone H3 in in vitro protein degradation assay. Primary outcome: protection of carH3 from neutrophil elastase degradation by anti-CarP antibodies

Description

This experiment evaluated the degradation kinetics of carbamylated histone H3 (carH3) by neutrophil elastase and tested whether anti-carbamylated protein (anti-CarP) IgG antibodies from rheumatoid arthritis patients could protect carH3 from proteolytic degradation. The study examined how antibody binding affects the stability of carbamylated proteins, which has important implications for autoantigen persistence in inflamed joints. The experiment involved incubating carH3 with neutrophil elastase in the presence or absence of patient-derived anti-CarP antibodies and measuring the remaining intact protein over time.

TARGET GENE
histone H3
MODEL SYSTEM
in vitro protein degradation assay
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
protein degradation, immune complex formation
SOURCE
extracted_from_pmid_41930627
PRIMARY OUTCOME
protection of carH3 from neutrophil elastase degradation by anti-CarP antibodies

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

Protocol

protein degradation kinetics assay, neutrophil elastase treatment, anti-CarP IgG incubation

Expected Outcomes

anti-CarP antibodies stabilize carH3 against proteolytic degradation

Success Criteria

reduced carH3 degradation in presence of anti-CarP antibodies

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.